healthcare
AstraZeneca Seeks US Drug Price Cuts Amid Expansion Plans, Strong Demand
Novo Nordisk Faces 'show Me' Moment to Boost Wegovy Growth After US Copycat Ban
HeadlinesGymnastics-Italy Withdraw From World University Games After Gymnast Seriously Injured in Fall
Sarepta Fails to Win EU Backing for Muscle Disorder Gene Therapy
AstraZeneca's Eco-Friendly Version of Smoker's Lung Inhaler Gets EU Panel Backing
Date: July 25, 2025
(Reuters) -A panel of the European medicines regulator has recommended approving an eco-friendly version of AstraZeneca's inhaler for the treatment of a chronic lung condition, the drugmaker said on...
EU Regulator Backs Gilead's Twice-Yearly Injection for Hiv Prevention
Date: July 25, 2025
(Reuters) -The European Union's drugs regulator has recommended approval of Gilead Sciences' lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents, the...
Novartis to Pay Matchpoint up to $1 Billion to Develop Anti-Inflammatory Therapies
Date: July 24, 2025
(Reuters) -Swiss drugmaker Novartis will pay up to $1 billion to U.S. biotech Matchpoint Therapeutics to develop oral drugs for several inflammatory diseases. Matchpoint said on Thursday it will use...
Roche Considering Selling Drugs Directly to US Patients, CEO Says
Date: July 24, 2025
By Bhanvi Satija and Maggie Fick LONDON (Reuters) -Roche is considering selling its prescription medicines in the U.S. directly to consumers to lower costs for patients as part of talks with the U.S....
Five Years After Covid, Pharma Shares Languish in US Policy Limbo
Date: July 23, 2025
By Danilo Masoni MILAN (Reuters) -Global healthcare stocks have not been this cheap in decades and fund inflows into the sector are picking up, yet the shares remain in the doldrums, highlighting...
India's Dr Reddy's Plans to Launch Generic Obesity Drugs in 87 Countries Next Year, CEO Says
Date: July 23, 2025
By Rishika Sadam HYDERABAD (Reuters) -Dr Reddy's Laboratories plans to launch a cheaper copycat version of Novo Nordisk's blockbuster weight-loss drug Wegovy in 87 countries next year, the Indian...